Skip to main content

Feature article: Creating a participation-based safety culture

6th June 2022

Submitted by:

Andrew Warmington

Sarah Ingle, who specialises in chemical safety and regulatory compliance at EcoOnline, explores how chemists can create a participatory safety culture

With news of Monkeypox’s emergence and possible mutation to become seen as the latest worrying infectious disease, I am reminded of shocking revelations in The Times last year. It divulged that there have been over 100 safety breaches at UK laboratories handling dangerous pathogens, over the past 15 years. Lapses included a worker being bitten by an infected ferret at Porton Down, the government’s high security research facility, and employees being exposed to TB bacteria.

While major viral leaks have been avoided, there clearly have been slip-ups. Considering the potential harm to human health that can result from these types of errors this does underline the need for constant vigilance and the need for robust safety procedures, and more importantly the creation of a positive safety culture.

Most of us, if we make a mistake, won’t release a potential pandemic on the world. But when working with hazardous substances we can still injure ourselves or others. Creating a positive safety culture I spent some of my earlier career in construction and spent time on sites where I saw things happen that would be unacceptable today.

The situation has vastly improved today, due to a deeply embedded culture change delivering a safer working environment. While lab-based work is very different in its nature, there are still potentially grave risks to health. Every organisation has, or should have, a safety culture. This can be positive or negative, depending on whether it has developed and implemented correctly within an organisation.

When incidents arise, it is because the existing culture is ineffective at keeping people safe from harm. Transforming this situation to achieve something fit-for-purpose requires consistency and an ongoing, targeted approach. Change takes time and requires constant communication and message reinforcement to people at all levels.

Inspire

We have all experienced tedious health and safety memos, briefings or posters, which are too often boring and jargon-heavy. While this is ticking the box, no-one’s behaviour will be changed. Frequently they opt for a ‘tell’ approach rather than looking to persuade.

There are seven principles of persuasion, which were devised by Cialdini: reciprocity, scarcity, authority, commitment, consistency, liking and consensus. By understanding these, you can use them to create a participation based safety culture. What works is being engaging, so be visual, be funny and use the unexpected.

While the topic is serious, you can still adopt a light touch. For example, Total Energy in Denmark made humour a core component in their behavioural safety campaign ‘don’t be a dummy’ which showed a crash test dummy undergoing various experiences which would maim or kill a human.1

Using humour creates a bonding experience which makes attitudinal shift possible and longer-lasting. It is tempting to regard H&S protocols as solely a lab matter. While this is important, the other teams, including senior management, play an important role as culture is set from the top. A recent HBR study shows that companies facing financial pressures saw higher levels of workplace accidents, as corners were cut to save money.2

So, the C-Suite should also beware of the unintended consequences of decisions made at board level. Leaders have to walk the walk, modelling excellent safety behaviour at all times. If we look to other industries e.g. heavy equipment manufacturing, many (rightly) ensure that office staff have to be safety-conscious, reversing into parking spaces or having lids on hot drinks when walking downstairs.

Employees and contractors also need to be able to speak truth to power, and to feel free to speak up when they can see improvements. This means creating a climate of ‘psychological safety’, a term coined by Professor Amy Edmondson of Harvard Business School. Her research includes evidence that companies with a trusting workforce perform better. As she says, “Psychological safety isn’t about being nice. It’s about giving candid feedback, openly admitting mistakes, and learning from each other.”

Assumption-free

In your organisation, there are likely to be highly educated professionals. In my experience there can sometimes be an assumption that because people hold doctorates, they will have a high degree of competency around chemical safety. However, regulations change, and working practices evolve, so in my best secondary school science reference, do not jump to any conclusions regarding policy, protocols and management.

We all know that humans are fallible and can make mistakes, so wherever possible look to remove steps where if something goes wrong harm could result. That is why a hierarchy of control is needed. This involves elimination, substitution, engineering controls, administration controls and PPE.

A systematic approach to working through the stages is required, along with regular documented reviews. Create a positive reporting culture where people can flag and log near misses or accidents, knowing managers will listen and act upon what they are told. If something is identified as risky. act upon it, and ensure there’s a way to guarantee this risk is not found elsewhere. Once again, inform those involved of changes made and that any necessary training happens.

Training & accountability

Training is key, and this has to be systematic and repeated. The importance of safety has to be clearly demonstrated from day one with a standardised induction. Training records must be kept, and with each session a safety angle needs to be incorporated. Personal accountability matters. Reward team members who improve safety performance and recognise their efforts. Involve employees in the safety decision-making process instead of dictating new policies and priorities.

When instituting a new development, explain to affected people why they are being asked to change what they normally do and what success will look like.  Ultimately, we need to be as close to zero risk as possible and this means everyone working together.

References:

1. https://ep.totalenergies.com/en/learn-more-about-us/best-innovators-2021/dont-be-dummy-awareness-raising-campaign-hits-home

2. https://hbr.org/2017/05/research-workplace-injuries-are-more-common-when-companies-face-earnings-pressure

Feature article – Saltigo rides out the cycle

Market and sustainability trends are positive drivers for Saltigo, despite the agro downturn. Andrew Warmington met up with the new CEO at Chemspec Europe

Submitted by:

Andrew Warmington

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical active ingredient (AI) manufacturing to its wholly owned subsidiary UPL Spec

Submitted by:

Andrew Warmington

Nippon Shokubai opens Indonesian plant

Japan’s Nippon Shokubai has officially opened a 100,000 tonnes/year acrylic acid (AA) plant that was built at a cost of about $200 million at Cilegon, Banten, Indonesia.

Submitted by:

Andrew Warmington

CABB to invest at Finnish agro site

The CABB Group has said that it will invest over €50 million by 2025 to expand facilities at its agrochemical manufacturing site in Kokkola, Finland.

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production planning of superabsorbent polymers (SAPs) based on acrylic acid, and has started operati

Submitted by:

Andrew Warmington

adcs

Three invest further into ADCs

Three CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.

Submitted by:

Andrew Warmington

Cambrex exits drug product

CDMO Cambrex has sold its Drug Product business unit to Noramco. Terms were not disclosed.

Submitted by:

Andrew Warmington

Siegfried breaks ground on R&D centre

Siegfried has broke ground for its new global R&D centre for drug substances at its site in Evionnaz, Switzerland.

Submitted by:

Andrew Warmington

Drug product centre opens

Following two years of construction work, CDMO Siegfried has officially opened its new development centre for drug products at its sites in Barberà del Vallès and El Masnou near Barcelona.

Submitted by:

Andrew Warmington

Evonik realigns Health Care

In order to “maximise customer centricity and market focus” and continue an ongoing transition into “a system solutions partner for the pharmaceutical and biotech industries”, Evonik has divided it

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants under the trade names AmphiCare and AmphiClean.

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based subsidiary of Seqens.

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in Austria have co-developed a computer-assisted regression model to improve enzyme performance and

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU and the Bio-based Industries Consortium (BIC) that funds projects advancing competitive circular bi

Submitted by:

Andrew Warmington

Investment in Tanasote plant

Octowood, a part of the Sweden’s Rundvirke Industrier Group, has invested in a new treatment plant using Arxada’s wood preservative, Tanasote.

Submitted by:

Andrew Warmington

Rhamnolipid milestone reached

Evonik has manufactured the first product from its industrial-scale biosurfactants facility at Slovenská Lupca in Slovakia.

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach Group in a move that it said would “create a global pigment company, combining SCIL’s ope

Submitted by:

Andrew Warmington

Lanxess to continue pigment production

Lanxess has reversed a decision to sell the chromium oxide pigments business at the Krefeld-Uerdingen site in Germany, preserving 50 jobs there.

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw materials, has announced a strategic collaboration with Japan’s Takasago, a large player in th

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site in Guangzhou. This triples its manufacturing capacity for fragrances and establis

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable fragrance ingredients from renewable carbon, with US-based LanzaTech, which describes i

Submitted by:

Andrew Warmington

Kao boosts jasmine fragrance

Japan's Kao Corporation is to double capacity for the synthetic fragrance methyl dihydrojasmonate (MDJ) at its site in Olesa, Spain, by adding a second production facility.

Submitted by:

Andrew Warmington

Merck KGaA “in a strong strategic position”

At its latest Capital Markets Day, Merck KGaA said that it is “in a strong strategic position” to profit from medium-term growth opportunities in all three of its business sectors after a transitio

Submitted by:

Andrew Warmington

Suez joins Global Impact Coalition

Suez, which describes itself as “a global leader in circular solutions for water and waste”, has joined the Global Impact Coalition (GIC).

Submitted by:

Andrew Warmington

Chemours opens battery lab

Chemours has opened Chemours Battery Innovation Centre (CBIC) at the Chemours Discovery Hub in Newark, Delaware.

Submitted by:

Andrew Warmington